Microbot Medical Inc. (HAM:CY9D) Financings

Microbot Medical Inc.

Financings

RaiseDate
Warrant exercise of common shares on exercise of outstanding preferred investment options
Closed: US$2.8M in the latest tranche · US$2.1 a share · Warrants at US$4.5 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Development, commercialization and regulatory work for the LIBERTY Robotic System, potential acquisitions, new applications, working capital
Oct 7, 2025
Registered direct offering of common stock with concurrent private placement of short-term series I preferred investment options
Closed: US$13M raised · US$2.13 a share · Warrants at US$2.13 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Development, commercialization and regulatory work for the LIBERTY Robotic System, new applications from its IP, working capital and general corporate purposes
Feb 11, 2025
Registered direct offering of common stock with concurrent private placement of short-term series H preferred investment options
Closed: US$8.6M raised · US$2.27 a share · Warrants at US$2.1 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Development, commercialization and regulatory activities for the LIBERTY Robotic System, new applications from its IP, working capital and general purposes
Jan 10, 2025
Registered direct offering of common stock with concurrent private placement of short-term series G preferred investment options
Closed: US$7M raised · US$1.75 a share · Warrants at US$1.75 for 24 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Development, commercialization and regulatory activities for the LIBERTY Robotic System, new applications from its IP, working capital and general corporate purposes
Jan 7, 2025
At-the-market programme of common stock
Tranche closed: US$4.8M raised
Jan 7, 2025

Read by 6ix AI from the company's releases